openPR Logo
Press release

Biosimilars Market 2019 - 2025; In-depth Analysis by Leading Players: Biocon, Samsung BioLogics, Mylan N.V., Amgen Inc., Celltrion, Healthcare Co.,Ltd., Sandoz International GmbH

01-21-2019 06:04 AM CET | Health & Medicine

Press release from: The Insight Partners

Biosimilars Market to 2025

Biosimilars Market to 2025

An exclusive Biosimilars Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Biosimilars Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Biosimilars Market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Get Sample Copy of this Report at http://bit.ly/2AVKFdb

The growth of the global biosimilars market can be attributed to the growing demand of pharmaceutical drug supplements, especially for the high priced patented drugs expected to upsurge the growth of the market. Additionally, increasing incidences of chronic diseases add novel opportunities for the global biosimilars market over the forecast period.

Leading Biosimilars Market Players:
1. Teva Pharmaceutical Industries Ltd.
2. Pfizer Inc.
3. Biocon
4. Samsung BioLogics
5. Mylan N.V.
6. Amgen Inc.
7. Celltrion Healthcare Co.,Ltd.
8. Sandoz International GmbH
9. STADA Arzneimittel AG
10. Dr. Reddy’s Laboratories Ltd.

A biosimilar is a biological product which is similar to an FDA approved biologic product of another manufacturer. Owing to the complexities associated with development & manufacture of biosimilar products, these are manufactured by companies with highly skillful workforce and deep scientific expertise. The FDA approval process for biosimilar products is rigorous and enables high safety to the end users.

Worldwide Biosimilars Market Analysis to 2025 is a specialized and in-depth study of the Biosimilars industry with a focus on the global market trend. The report aims to provide an overview of global Biosimilars Market with detailed market segmentation by product/application and geography. The global Biosimilars Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the players and offers key trends and opportunities in the market.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Biosimilars Market based on product and application. It also provides market size and forecast till 2025 for overall Biosimilars Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

To Know More Inquire @ http://bit.ly/2AV2R6B

Also, key Biosimilars Market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Reason to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Biosimilars Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Biosimilars Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

To Buy This Informative Research Report, Please Click On The Link @ http://bit.ly/2AU3IEw

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market 2019 - 2025; In-depth Analysis by Leading Players: Biocon, Samsung BioLogics, Mylan N.V., Amgen Inc., Celltrion, Healthcare Co.,Ltd., Sandoz International GmbH here

News-ID: 1514883 • Views: 413

More Releases from The Insight Partners

Chatbot Market trend shows a rapid growth by 2027- Nuance Communications, Artifi …
Chatbot is a type of artificial intelligence systems which interacts with the users through speech, text, and messaging. With the increasing demand and usage of messaging applications made easy accessibility of customized bot and therefore strengthen the growth of Chatbot market. There are many Chatbot platform present like WeChat, Facebook messenger, WhatsApp among others, all these chatbots has become the necessity for many industries. The increasing demand of computerized patient
Mixed Reality in Gaming Market 2019-2027 Study includes Top Key Players as Micro …
Mixed Reality (MR) in Gaming is a technology combining real environment and virtual world which increases efficiency by reducing time in product designing. MR is also termed as hybrid reality, it produces new surrounding and visualizations where physical and digital objects stands and interacts in real time. As demand for smartphone, tablet is increasing, it is offering a large scope to MR also. More to it, for giving proper and
Event Stream Processing Market to 2027 - Google, IBM, Informatica, Microsoft, Or …
The analysis of the global Event Stream Processing Market 2027 is an in-depth study of the Event Stream Processing industry, which focuses on global market trends. The report aims to provide an overview of the global market for Event Stream Processing with detailed market segmentation by product / application and by region. The global market for Event Stream Processing is expected to experience strong Growth over the forecast period. The reports
System of Insight Market to 2027 - GoodData, IBM, INETCO Systems, Medallia, NGDA …
The analysis of the global System of Insight Market 2027 is an in-depth study of the System of Insight industry, which focuses on global market trends. The report aims to provide an overview of the global market for System of Insight with detailed market segmentation by product / application and by region. The global market for System of Insight is expected to experience strong Growth over the forecast period. The reports

All 5 Releases


More Releases for Biosimilars

PHASE-XS – Access To Life Changing Biosimilars
Biopharmaceutical is one of the fastest growing industries with addition of numerous biologics that provide novel treatment modalities for life-threatening and rare diseases. Biologics are produced from living organisms through unique manufacturing and purification processes. It includes a wide variety of products such as vaccines, blood, blood components, cells, allergens, genes, tissues, and recombinant proteins that are derived from human, animal or microorganisms by using biotechnological procedures. Some examples for
Global Biosimilars Market Research Report
This report studies the global Biosimilars market status and forecast, categorizes the global Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy’s Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. The patent protection assigned to Humira will expire in 2016 for US and 2018 for European market.
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 5 biosimilar version of Enbrel are commercially available in Iran, Mexico, India, UK and Australia. The patent on Enbrel was originally set to expire on